OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
July 23, 2021
Cliodhna McDonough-Stevens looks at what the COVID-19 pandemic might mean for the future of cell and gene therapy across Europe.
July 06, 2021
Jenny Sherak, SVP & President of Specialty Physician Services at AmerisourceBergen, talks about how the needs of physician practices have evolved during the COVID-19 pandemic and what is required to navigate the shifting healthcare landscape.
The Center for Biologics Evaluation and Research’s top priority is to approve biologics license applications (BLAs) to address vaccine hesitancy, according to CBER director Peter Marks.
June 09, 2021
How Gilead readied remdesivir for the COVID challenge.
Inside Regeneron’s monoclonal antibody development to treat COVID.
Past lessons, strong resolve, and complex coordination propel J&J’s vaccine efforts.
Thrust into a commercial-stage company in just months, Moderna moves full steam ahead.
College roommates, industry partnerships help bring Pfizer vaccine to fruition.
June 07, 2021
Biden administration supports a notable increase in funding for public health and research as a lead priority for the coming year.
June 01, 2021
It's time to apply the same COVID-19 urgency to other devastating diseases, such as Alzheimer’s, write Andrea Pfeifer and William Mobley.